The Function of Large Vessels in Normal-Weight and Overweight Children With Psoriasis During Methotrexate Therapy

Background. In recent years, the opinion has been established that skin manifestations of psoriasis are associated with the damage of other organs and systems, and that psoriatic lesions have a systemic nature, and therefore the term ‘psoriatic disease’ is increasingly used in scientific literature. Among psoriasis comorbidities, metabolic disorders and cardiovascular diseases are of particular clinical importance. Our aim was to study the effect of systemic cytostatic therapy with methotrexate on the remodelling processes of large vessels in children with psoriasis who have normal and increased body mass index. Methods. The primary data was collected by extracting data from medical records and case follow-up records. The subsequent accumulation, storage, grouping and primary sorting of research data were carried out using a personal computer and Excel application package. Clinical evaluation of the severity of psoriasis and skin lesions was assessed by calculating the PASI index. Non-invasive oscillometric arteriography was performed on a portable ArterioGraph (TensioMed Ltd, Hungary). Results. A direct significant correlation has been established between the revealed impairments of the function of large arteries and the indicators of fat metabolism, the severity of psoriasis and body mass index. During the systemic pathogenetic cytostatic therapy with methotrexate, a significant positive dynamics of the function parameters of large arteries was revealed in children with psoriasis who have both normal and increased body mass index. Conclusion. The undertaken studies showed that methotrexate is an effective and safe agent for treating psoriasis in children aged from 3 to 18 years, has a positive effect on the function of large vessels.

Nikolay N. Murashkin — receiving research funding from pharmaceutical companies Jansen, Eli Lilly. Receiving fees for scientific advice from Galderma, Pierre Fabre, Bayer, Astellas, Libriderm.

Alexander I. Materikin — receiving research funding from pharmaceutical company Eli Lilly. Receiving fees for scientific advice from Bioderma, Libriderm.

1. Мурашкин Н.Н. Современные особенности клинического полиморфизма, эпидемиологических и медико-социальных характеристик дерматозов с хроническим течением в детском возрасте (на примере Краснодарского края): Дис. … докт. мед. наук. — М.; 2011. — 254 с. [Murashkin N.N. Sovremennye osobennosti klinicheskogo polimorfizma, jepidemiologicheskiсh i mediko-social’nyсh harakteristik dermatozov s hronicheskim techeniem v detskom vozraste (na primere Krasnodarskogo kraja). [dissertation] Moscow; 2011. 254 р. (In Russ).] Доступно по: https://search.rsl.ru/ru/record/01005084683. Ссылка активна на 14.09.2018.

2. Moebus S, Balijepalli C, Lösch C, et al. Age- and sex-specific prevalence and ten-year risk cardiovascular disease of all 16 risk factor combination of the metabolic syndrome — a cross-sectional study. Cardiovasc Diabetol. 2010;9:34. doi: 10.1186/1475-2840-9-34.

3. Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26 Suppl 2:3–11. doi: 10.1111/j.1468-3083.2011.04410.x.

4. Armstrong AW, Voyles SV, Armstrong EJ, et al. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011;20(7):544–549. doi: 10.1111/j.1600-0625.2011.01308.x.

5. Augustin M, Glaeske G, Radtke MА, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633– 636. doi: 10.1111/j.1365-2133.2009.09593.x.

6. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. The inflammatory response in mild and in severe psoriasis. Br J Dermatol. 2004;150(5):917– 928. doi: 10.1111/j.1365-2133.2004.05984.x.

7. Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M. C-reactive protein and a2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol. 2004;18(2):180–183. doi: 10.1111/j.1468-3083.2004.00863.x.

8. Chen YJ, Shen JL, Wu CY, et al. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol. 2009;60(2):225–230. doi: 10.1016/j.jaad.2008.09.046.

9. Kwa M, Silverberg JI. Association between inflammatory skin disease, cardiovascular and cerebrovascular comorbidities in US adults: analysis of nationwide inpatient sample data. Amer J Clin Derm. 2017;18(Issue 6):813–823. doi: 10.1007/s40257-017-0293-x.

10. Benetos A, Waeber B, Izzo J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens. 2002;15(12):1101–1108. doi: 10.1016/ s0895-7061(02)03029-7.

11. Кожевникова О.В. Факторы риска и маркеры ранней диагностики сердечно-сосудистых болезней у детей: Дис. … докт. мед. наук. — М.; 2016. — 311 с. [Kozhevnikova O.V. Faktory riska i markery rannei diagnostiki serdechno-sosudistykh boleznei u detei. [dissertation] Moscow; 2016. 311 р. (In Russ).] Доступно по: http://nczd.ru/ wp-content/uploads/2018/04/diss-kojevnikova.pdf. Ссылка активна на 26.09.2018.

12. Мадаева И.М., Шевырталова О.Н., Долгих В.В. Артериальная гипертензия и нарушения дыхания во время сна в педиатрии: результаты пилотного исследования // Педиатрия. Приложение к журналу Сonsilium medicum. — 2009. — №3 — С. 114–116. [Madaeva IM, Shevyrtalova ON, Dolgikh VV. Arterial’naya gipertenziya i narusheniya dykhaniya vo vremya sna v pediatrii: rezul’taty pilotnogo issledovaniya. Pediatrics. 2009;(3):114–116. (In Russ).]

13. Кожевникова О.В., Намазова-Баранова Л.С., Логачёва О.С., и др. Пульсовое артериальное давление и показатели ремоделирования сосудов: поиск ранних признаков развития сердечно-сосудистой патологии у детей // Вопросы современной педиатрии. — 2015. — Т.14. — №1 — С. 119–123. [Kozhevnikova OV, Namazova-Baranova LS, Logachyova OS, et al. Pul’sovoe arterial’noe davlenie i pokazateli remodelirovaniya sosudov: poisk rannikh priznakov razvitiya serdechno-sosudistoi patologii u detei. Current Pediatrics. 2015;14(1):119–123. (In Russ).]